BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 26082353)

  • 21. Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience.
    Jelušić M; Kronja M; Frković M; Sršen S; Huljev Frković S; Štekić Novački K
    Acta Clin Croat; 2018 Jun; 57(2):307-311. PubMed ID: 30431724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophagocytic lymphocytic histiocytosis/macrophage activation syndrome with acute inflammatory gastroenteritis.
    Kolachana S; Malik A; Nanjudappa A; Iding J; Bhansali D; Haas CJ
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36002177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
    Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
    J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
    Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
    Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    Vandenhaute J; Wouters CH; Matthys P
    Front Immunol; 2019; 10():3089. PubMed ID: 32010140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage Activation Syndrome.
    Sen ES; Clarke SL; Ramanan AV
    Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM; Møller HJ; Larsen JB
    Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
    Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
    Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Minoia F; Davì S; Horne A; Bovis F; Demirkaya E; Akikusa J; Ayaz NA; Al-Mayouf SM; Barone P; Bica B; Bolt I; Breda L; De Cunto C; Enciso S; Gallizzi R; Griffin T; Hennon T; Horneff G; Jeng M; Kapovic AM; Lipton JM; Magni Manzoni S; Rumba-Rozenfelde I; Magalhaes CS; Sewairi WM; Stine KC; Vougiouka O; Weaver LK; Davidsone Z; De Inocencio J; Ioseliani M; Lattanzi B; Tezer H; Buoncompagni A; Picco P; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    J Rheumatol; 2015 Jun; 42(6):994-1001. PubMed ID: 25877504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage activation syndrome and cytokine-directed therapies.
    Schulert GS; Grom AA
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
    Henderson LA; Cron RQ
    Paediatr Drugs; 2020 Feb; 22(1):29-44. PubMed ID: 31732958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
    Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
    Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Ko G; Saikawa Y; Kubota T; Yamasaki Y; Takei S; Yachie A
    Clin Immunol; 2015 Oct; 160(2):277-81. PubMed ID: 26101092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Macrophage activation syndrome in children with rheumatic disorders: a retrospective study on 6 patients].
    Hu J; Li CW; Ma JJ; Yin J; Wang XM; Huang WY; Zhang YM
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):818-23. PubMed ID: 17274867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic defects in cytolysis in macrophage activation syndrome.
    Zhang M; Behrens EM; Atkinson TP; Shakoory B; Grom AA; Cron RQ
    Curr Rheumatol Rep; 2014; 16(9):439. PubMed ID: 25086802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Inoue N; Schulert GS
    Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.